1. Home
  2. ESLT vs ONC Comparison

ESLT vs ONC Comparison

Compare ESLT & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elbit Systems Ltd.

ESLT

Elbit Systems Ltd.

HOLD

Current Price

$685.78

Market Cap

33.9B

Sector

Industrials

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$346.65

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESLT
ONC
Founded
1966
2010
Country
Israel
Switzerland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.9B
34.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ESLT
ONC
Price
$685.78
$346.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$550.33
$369.50
AVG Volume (30 Days)
131.8K
304.0K
Earning Date
03-17-2026
02-26-2026
Dividend Yield
0.38%
N/A
EPS Growth
68.63
N/A
EPS
9.87
0.58
Revenue
$7,720,284,000.00
$4,972,687,000.00
Revenue This Year
$18.47
$895.40
Revenue Next Year
$10.93
$22.04
P/E Ratio
$72.98
$592.40
Revenue Growth
18.35
50.43
52 Week Low
$294.99
$196.45
52 Week High
$740.67
$385.22

Technical Indicators

Market Signals
Indicator
ESLT
ONC
Relative Strength Index (RSI) 52.30 58.63
Support Level $690.00 $328.91
Resistance Level $721.76 $353.00
Average True Range (ATR) 22.06 9.40
MACD -9.46 0.45
Stochastic Oscillator 6.60 75.30

Price Performance

Historical Comparison
ESLT
ONC

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: